Posted by AGORACOM-JC
at 1:40 PM on Thursday, January 6th, 2022
Valeo Pharma is already a successful, revenue-generating, small-cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.
This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small-cap pharma companies.
The company released stellar a Q3 with the following highlights:
Record revenues of $5.7 million for Q3 2021, up 280% over Q3 2020 and 114% over prior quarter.
Record gross margin of $2.2 million , up 1602% over Q3 2020 and 204% over prior quarter.
Record 9 months revenues at $10.2 million , up 94%
Approved by Health Canada for immune support, is now available for sale in approximately 300 stores under the Loblaw’s banners including:
Loblaws
Dominion,
Zehrs,
Fortinio’s,
Your Independent Grocer and Superstore
Steve Saviuk , CEO commented,
We are very pleased to announce that Hesperco is now available in over 300 Loblaw banner stores. The immune support properties of hesperidin, the sole medicinal ingredient contained in Hesperco capsules, has been well documented in numerous scientific publications. We are also encouraged by the results of the Hesperidin Covid-19 clinical trial which has recently been submitted for publication. The study concluded that hesperidin could have beneficial effects and may help reduce certain Covid-19 symptoms. The publication further suggested that earlier treatment of longer duration and/or higher dosage should be studied.”
Posted by AGORACOM-JC
at 6:11 PM on Wednesday, January 5th, 2022
The genesis of Liquid Avatar Technologies is a global blockchain & personal identity solutions company specializing in empowering individuals to manage, control and generate value from their biometrically-verified digital Identity, which also provides businesses and governments the ability to easily integrate digital wallets and digital identity solutions through its Liquid Avatar platform (www.liquidavatar.com)
And if the story ended there, that would be more than enough to build a company on.
However, as the digital universe has continued to expand, there is an ever-increasing need to verify online identity as governments and enterprises around the world prepare for the shift. For example:
In early 2021 Google announced a major shift away from precision-targeting of ads based on everything you do on the internet
The Ontario Government released its Digital Strategy, with key themes including the launch of Digital ID credentials.
“Ontario is one of the first jurisdictions in North America to announce that it will issue and enable digital credentials – and it has been a great experience working with the government on this both directly and through our role in membership organizations like the Trust Over IP Foundation,
As a result, the Liquid Avatar Verifiable Credentials Ecosystem (LAVCE) is being built to support all participants in a digital credential ecosystem. Almost immediately, Liquid Avatar announced a big win here by partnering with the Ontario Convenience Stores Association (OCSA) To Provide Digital Age-Verification Solutions To Over 8,000 Stores.
Again, if the story ended there, Liquid Avatar would have the makings of a potentially massive tech company.
But with the rise of NFTs and the Metaverse, both of which strongly rely on digital identity, the Company continued to expand its core digital identity technology into these areas and registered major successes, including $1,000,000 in Preliminary Gross Revenues for its Aftermath Islands Metaverse.
“Our in-market businesses continued to perform above expectations for Q4, and we remain optimistic, while cautious, as these are still early days in the Company’s transformation to an active revenue organization. We have started to witness online acceptance of digital identity programs, which are at the core of all our solutions, and both avatar and metaverse activities are gaining traction, creating opportunities for early revenue there, as the industry embraces the future of Web 3.0. Our goal is to continue to create value for all our stakeholders.”
If you believe in the future of Web3 (blockchain, crypto, tokens, NFTs and the Metaverse) and looking for a small cap company to help you participation in it, then look no further than Liquid Avatar.
Watch this powerful interview with CEO David Lucatch.
Posted by AGORACOM-JC
at 4:24 PM on Thursday, December 30th, 2021
FOBI AI is a global leader in digital wallet pass technology that delivers real-time data analytics and engagement through artificial intelligence to drive customer activation and engagement in stores, stadiums, arenas, hotels and other large venues around the world.
More than just lip service, FOBI AI is firing on all cylinders. Here are just some of the highlights from December:
Posted by AGORACOM-JC
at 10:18 AM on Saturday, December 25th, 2021
The Roundup
A weekly summary of Novamind news and media
Dr. Steve Thayer with an important reminder that, for some, the holidays can be a difficult time of year for many reasons. He shares tips to care for our mental health and wellbeing over the holidays.
We are pleased to announce the signing of a definitive agreement to acquire Arizona-based Foundations for Change, a mental health practice specialized in ketamine-assisted psychotherapy, from its sole stockholder, Jeff Edelman. The transaction is subject to regulatory approvals and is expected to close in January 2022.
Opened in 2017 by Jeff Edelman, Foundations currently operates one outpatient mental health clinic in Peoria, Arizona with an annual revenue run rate in excess of US$800,000 and owns a second, larger location in Phoenix that is scheduled to open in early 2022. Foundations will temporarily operate as “Foundations for Change by Novamind” until the Company completes its recently announced rebrand. Mr. Edelman will continue in a leadership capacity as Medical Director for both clinics. Mr. Edelman is double board-certified Family Psychiatric-Mental Health Nurse Practitioner and a Child and Adolescent Psychiatric-Mental Health Clinical Nurse Specialist. As a former military combat veteran, who served in the US Army 55th Medical Co. Combat Stress Control unit, Mr. Edelman has special expertise in treating military veterans and first responders who struggle with stress and trauma.
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison catch up after their recent trip to the “Horizons: Perspectives on Psychedelics” conference in New York. Stay tuned next week for our last episode of 2021 and a special PTF podcast contest and giveaway.
NBC News reports on a first-of-its kind clinical trial at the University of Washington School of Medicine to treat 30 medical professionals experiencing depression with a dose of synthetic psilocybin combined with psychotherapy. Some say that even five years ago, this would have been considered taboo. “That medical researchers are turning toward psilocybin to treat colleagues is representative of a growing curiosity and acceptance of the drug among those in the medical establishment.” We’re seeing that openness, too, through our Frontline KAP clinical pilot to help healthcare workers heal.
Posted by AGORACOM-JC
at 5:20 PM on Tuesday, December 21st, 2021
We all remember the crash of “blockchain” stocks a couple of years back, which was actually a crash of blockchain pretenders who used the term to build stock promotions, as opposed to building actual blockchains.
Like the dot-com crash of 2000, which bankrupted “dot-com” companies but gave birth to the likes of Google, Amazon, Linkedin because they built actual utility and value, the same could be expected of the blockchain crash and its’ resurgence.
But Blockchain Foundry is only just getting started. The Company is building a WEB3 ecosystem on top of its powerful Sycoin blockchain which is the 2nd most secure blockchain in the world next to Bitcoin. That isn’t a typo and Web3 coin investors believe it given the fact it has traded over $13,000,000 in volume over the last 24 hours … and close to $25,000,000 in the 24 hours before that!
What do they know that small cap investors don’t know? What to Web3 investors know that isn’t being reflected in the $BCFN stock price? The short answer is .. A Lot … but luckily we were able to tear away CEO Dan Wasyluk from his coding marathons to explain exactly what we are missing by going through the Company’s power point presentation.
If you’re a small cap investor looking for exposure to the Web3 world of blockchain, coins, tokens, NFTs and more then this $BCFN presentation is a must-watch.
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison are joined by Jeremiah Robison to talk about work-life balance. Jeremiah is the Founder and CEO of Shroom Beach, a psychedelic-inspired clothing company that donates 10% of its profits to fund psychedelic medicine research
Both articles highlight how the new clinic will focus on treating substance use disorders and addiction-related illnesses led by incoming medical director Amy de la Garza.
Blossom summarizes the exciting progress made on treating eating disorders with psychedelics. It’s a passion which our Chief Medical Officer, Dr. Reid Robison shares, working for years to bring innovative and effective treatment options to people suffering. Recently, Dr. Robison presented a keynote on the topic at the MindMed Australia International Summit on Psychedelic Therapies for Mental Illness. You can watch it here.
Three more Canadians received legal access in a big win that “opens it up to everyone,” but there are still issues with the system overall. “The process is still broken.” The Vancouver Sun explores how even with such positive news, there is still a lot of ground to cover in Therapsil’s fight for expanded access to psychedelic medicine.
No. We are not out of the woods. The Omicron variant is spreading quickly and with it, a slew of public health restrictions and fears reminiscent of March 2020. What can’t get lost in the shuffle again is addressing mental health. Especially for those on the frontlines of healthcare. “This sense of endlessness, accompanied by growing psychological distress leading to depression, was a recurrent theme in two dozen interviews conducted in Asia, Europe, Africa and the Americas. After two years of zigzagging policy and roller coaster emotions, terrible loss and tantalizing false dawns, closing borders and intermittently shuttered schools, people’s resilience has dwindled.” Frontline ketamine-assisted psychotherapy registration is still open for the next group of participants. Learn more here.
Posted by AGORACOM-JC
at 4:38 PM on Friday, December 17th, 2021
Valeo Pharma is already a successful, revenue-generating, small cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.
This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small cap pharma companies.
Q3 Highlights:
Record revenues of $5.7 million for Q3 2021, up 280% over Q3 2020 and 114% over prior quarter.
Record gross margin of $2.2 million , up 1602% over Q3 2020 and 204% over prior quarter.
Record 9 months revenues at $10.2 million , up 94%
Public reimbursement now includes Alberta , Quebec and Nova Scotia , representing approximately 37% of the Canadian population.
More than 90% private insurance coverage across Canada
Frederic Fasano, Valeo’s President and Chief Operating Officer commented,
“We are pleased to be reporting today the addition of Quebec and Nova Scotia to join Alberta on the list of provincial public coverage secured for both asthma medications. Public Reimbursement access makes a meaningful impact for asthma patients left with no coverage so far, and also simplify health care providers procedures to provide access of both medications to their patients. Enerzair and Atectura are innovative asthma therapies that are helping make asthma control a more attainable goal for Canadians asthma patients”.
Posted by AGORACOM-JC
at 9:09 AM on Thursday, December 16th, 2021
An emerging esports and iGaming company that is creating an Esports adventure like no other …. Create the world’s foremost esports and iGaming ecosystem.
The global online gambling market could potentially hit $1 TRILLION by the end of this decade. The obvious reasons include the following:
Exponential growth in the number of people online. Yet only 59% of the world means more to come.
Fast growth in the number of countries and jurisdictions legalizing gambling to collect tax revenue.
Esports was already the fastest growing sub-sector of digital entertainment, and Covid 19 has only accelerated this trend.
Biggest brands/tournament prizes / online audiences in the world … 500M +
The International Olympic Committee has recognized esports as a sport, and it will be a medal event at the 2022 Asian Games
Despite the vast amount of viewers, esports is still dramatically under-monetized relative to traditional sports. ITM believes wagering will play a major role in helping monetize this ever-evolving platform.
Intema has had an active first half of December evident by the following:
Goal of expanding Intema’s esports and iGaming operations in the U.S.
letter of intent with Wild Rose Entertainment to operate a LOOT.BET sports wagering skin in the state of Iowa
Betting handle in Iowa estimated at more than US$1 billion in 2021, having reached $287 million in November 2021 (Source: gambling.com, December 10, 2021)
Laurent Benezra, President and CEO of Intema,
“We are thrilled to welcome Bill to the Intema team and are impressed with what he has managed to accomplish in a very short period of time. The LOI with Wild Rose is just the beginning of what the LOOT.BET platform could bring to Intema once its acquisition is finalized.”
“The grant of the Isle of Man gambling license is major news for Intema and will have a significant positive impact on our future activities. In particular, it allows us to comply with one of the TSX Venture Exchange’s main conditions for closing the acquisition of Livestream Gaming Inc. (“ Livestream ”), with its LOOT.BET online gaming platform. It will also enable us to conduct our iGaming activities through one of the world’s most prestigious gaming jurisdictions and, once we acquire our LOOT.BET platform, to white-label it to regulated gaming markets on a global scale. Finally, it gives LOOT.BET the same level of credibility as other online gambling platforms, throughout the gaming community and among our peers.”
Sit back, relax and watch this powerful interview.
Review confirms Q by SoLVBL’s security, reliability and operational excellence, while reducing overall operational workload risks for cloud-based applications.
The Functional Technical Review (“FTR”) also confirmed the speed and functionality of Q by SoLVBLTM, as well as providing SoLVBL with data required to develop a cost model.
This successful trial, with all objectives achieved, will enhance SoLVBL’s continuing marketing and sales efforts.
SoLVBL Solutions and Empower Clinics Sign Memorandum of Understanding (MoU) to Develop a Program for Data Security in Diagnostic Testing
“We are excited to collaborate with SoLVBL Solutions, a company with broad know-how in data verification and cybersecurity. The collaboration agreement entered with Empower combines SoLVBL Solutions’ data verification capabilities with Empower’s experience and extensive expertise in the design, construction, operation, and maintenance of healthcare clinics and world-class diagnostic laboratories. With the increase in data collection, the demand to protect and verify data is unprecedented. We have seen such announcements come from both the Canadian and American governments. We feel this verification solution will allow us to continue to grow and meet the demands and needs of our patients and health care administrations. The collaboration aligns with our expansion and growth plans to become a global technological leader in the healthcare diagnostic sector.” said Steven McAuley, CEO of Empower.
Data Security Today
We live in a digital data age
Data is critical for the present and future of automation, AI, IoT, analytics etc.
As decisions become more automated, data integrity becomes even more crucial
The cyber security market size was valued at $149.67 billion in 2019 and is projected to reach $304.91 billion by 2027
North America accounts for 45% of market
Data Forgery
Data is the “new gold”
Forgery, hacking is a growing problem in the data world.
In a world increasingly reliant upon more and faster data for automated decision-making, operational efficiency and competitive advantage, data integrity and protection is critical to ensure a client’s data is not a liability.
Solving the problem
In the physical world fraud can be detected by using physical tools to detect alterations, such as hand writing analysis, watermarks, age of paper etc. In the digital world, which comprises of 1’s and 0’s, there is no way of knowing if the 1’s and 0’s have been altered, unless you use Q by SoLVBL.
Q by SoLVBL
So… what technology does this replace?
Q by SoLVBL™ operates dramatically faster and at lower latency than the alternative today, Digital Ledger Technology (DLT)—commonly referred to as Blockchain. This in turn enables data uses and applications DLT does not support.
The Q by SoLVBL™ protocol produces a unique digital seal for each submitted record.
What can this technology be used for?
Link the record to the possessor of a private signing key, i.e. an identity
Determine relative ordering of records sealed in this manner
Uniquely identify an instance of the record by way of its seal (each seal reflects an instance)
Is Q by SoLVBL™ difficult / expensive to implement? Or is it an add-on?
Cost-effective to implement
May be integrated with existing application in a straightforward manner, wherever data is created, stored or used.
Whether Q by SoLVBL™ is applied as an add-on or technology replacement depends on the architecture needs and maturity of the system in which it is used.
Who are the company’s competitors?
Users seeking such assurances will typically gravitate towards various Blockchain or Distributed Ledger Technologies (DLT).
Significant shortcoming of DLT is that the inherently decentralized nature of these technologies causes them to impose prohibitive latency or bandwidth limitations on their users.
Q by SoLVBL™ can process 150,000 transactions per second at a minimum, and millions per second depending upon the application.
Our Vision “Our dream is a world in which every digital record’s authenticity can be established quickly and irrefutably to create trust fast.”
Our Mission “To empower better, faster decisions by developing a universal standard for establishing digital record authenticity which is easy to adopt, cheap to use, offers cryptographic assurances, and will not bottleneck systems.”
**
WHY SOLVBL
SoLVBL’s innovative integrity solutions give clients and customers added trust to ensure their data is an asset
Cost of data security is significant
The finance and insurance sector were the most- attacked industry in 2019, with retail payments second
Data security & privacy segment expected to outpace total cyber security growth
Data is valuable and important. Should be asset not liability
Highlights
– Q by SoLVBL is a cryptographically verified, patented, best-in-class cybersecurity product;
– Q by SoLVBL is simple to use;
– Enhanced confidentiality, by never needing to see your data;
– It is compatible with existing systems, so no expensive hardware/software updates;
– Q by SoLVBL is fast. Q can process in excess of 150,000 transactions/second; and
– Our Software as a Service (SaaS) model is very cost effective to the client.
– SoLVBL announces first Memorandum of Understanding (MoU) in the Financial Services Sector, with QuantGate Systems to Develop a Program for Data Security
– Allow to further demonstrate its capabilities around data security and speed of transactions
Salt Lake City Clinic welcomes incoming addictions specialist, Dr. Amy de la Garza
We are pleased to announce the opening of a new clinic located in downtown Salt Lake City (SLC). In addition to Novamind’s suite of mental health treatments, the SLC Clinic specializes in integrative behavioural health and services for adults with substance use disorders (SUD) led by incoming Medical Director, Dr. Amy de la Garza.
The SLC Clinic’s outpatient SUD services provide an alternative to residential treatment programs and work to address the highly complex public health crisis that is worsening alongside challenges related to access. In 2020 alone, 93,000 Americans died of a drug overdose-an increase of 30 per cent from the previous year, according to the Centers for Disease Control and Prevention.
Dr. Reid Robison, Novamind’s Chief Medical Officer, commented: “Social isolation and despair related to the COVID-19 pandemic have further fueled a significant increase in substance use disorders and related deaths. Dr. de la Garza’s expertise in addiction medicine and behavioural health is a vital addition to our team as we continue to expand Novamind’s clinic footprint to address unmet need and broaden our innovative, evidence-based treatments.”
Dr. de la Garza is a board-certified family practice physician with 10 years of experience providing specialized care for patients with behavioral health and SUD diagnoses. She earned her Doctorate in Medicine from the University of Colorado before completing a Family Medicine Residency at the Utah Healthcare Institute. She also completed an Addiction Medicine Fellowship at the University of Utah and is an Institute for Functional Medicine Certified Practitioner. In 2017, Dr. de la Garza opened the first community-based, co-located primary care and behavioral health practice in Salt Lake City, Utah.
“I am thrilled to join Novamind and look forward to establishing an innovative outpatient substance use disorder program that brings together addiction and integrative medicine and treats the whole person,” said Dr. de la Garza, who is also trained in integrative modalities and lifestyle medicine, including nutrition, movement, sleep, stress management and social connection.
Novamind will collect clinical data on the efficacy of the integrative treatment approach for SUD and host upcoming studies for conditions like opioid use disorder. Additionally, the SLC Clinic will pilot an innovative and cost-effective group medical visit model that has been shown to reduce anxiety and depression, as well as improve outcomes in chronic conditions like cardiovascular disease and diabetes.
The SLC Clinic is located at 807 E South Temple, Suite 101, Salt Lake City, Utah.
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison explore anxiety. They discuss the following topics and much more: • What is an anxiety disorder? • Anxiety management skills • The role of medicines in treating anxiety
Utah Business covers Dr. Reid Robison and the success of ketamine-assisted psychotherapy in our clinics. “While it’s still early and much more testing is to be done, Robison describes what’s happening in mental health care as a ‘psychedelic renaissance’.”
Dr. Reid Robison, Matt Johnson and Robin Carhart-Harris discuss The Science of Psychedelics: Therapeutic mechanisms and clinical outcomes for a range of mental illnesses and other conditions.
Chief Medical Officer Dr. Reid Robison’s keynote presentation at the Mind Medicine Australia International Summit on Psychedelic Therapies for Mental Illness.
“While the U.S. has been battling Covid-19 it’s gotten lost in the shuffle that the nation had record numbers of drug overdose-related deaths in 2020; approximately 93,000. In addition, from May 2020 through April 2021, the figure rises to 100,000.” We need better treatment options for people with substance use disorders (SUD). It’s the driving force behind why incoming Novamind Medical Director Dr. Amy de la Garza will lead SUD programming at our new Salt Lake City clinic.
We are currently in a mental health crisis. Depression, anxiety and symptoms of PTSD have run rampant over the last two years, accelerated by the COVID-19 pandemic and its far-reaching effects. The need for new and effective mental health treatments has never been clearer. We have seen the efficacy of ketamine-assisted psychotherapy firsthand. And we are eager to continue psychedelic research. If you’d like to stay up to date on upcoming studies hosted by Novamind, visit us here and get in touch. “So what else does the future hold for psychedelics? For one thing, taking psychedelics could one day be the same as taking an everyday pill prescribed by your doctor.”
